Achieve Life Sciences, Inc. (FRA:SP4P)

Market Cap	192.94M +73.4%
Revenue (ttm)	n/a
Net Income	-44.61M
EPS	-1.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	524
Open	3.640
Previous Close	3.490
Day's Range	3.640 - 3.640
52-Week Range	1.732 - 4.970
Beta	n/a
RSI	46.29
Earnings Date	Mar 13, 2026

About Achieve Life Sciences

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

• Industry: Pharmaceutical Preparations
• CEO: Richard A. Stewart
• Employees: 25
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SP4P

Financial Performance

Financial numbers in USD